Below are the most recent publications written about "Exanthema" by people in Profiles.
-
Lavery MJ, Parish LC. The history of annular lesions of skin diseases. Clin Dermatol. 2022 Sep-Oct; 40(5):414-419.
-
Nathan P, Hassel JC, Rutkowski P, Baurain JF, Butler MO, Schlaak M, Sullivan RJ, Ochsenreither S, Dummer R, Kirkwood JM, Joshua AM, Sacco JJ, Shoushtari AN, Orloff M, Piulats JM, Milhem M, Salama AKS, Curti B, Demidov L, Gastaud L, Mauch C, Yushak M, Carvajal RD, Hamid O, Abdullah SE, Holland C, Goodall H, Piperno-Neumann S. Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. N Engl J Med. 2021 09 23; 385(13):1196-1206.
-
Maniaci A, Iannella G, Vicini C, Pavone P, Nunnari G, Falsaperla R, Di Mauro P, Ferlito S, Cocuzza S. A Case of COVID-19 with Late-Onset Rash and Transient Loss of Taste and Smell in a 15-Year-Old Boy. Am J Case Rep. 2020 Aug 20; 21:e925813.
-
Wolf R, Parish LC, Parish JL. The rash from nuisance to life threatening: Part II. Clin Dermatol. 2020 Jan - Feb; 38(1):1-2.
-
Wolf R, Parish JL, Parish LC. The rash that presents as target lesions. Clin Dermatol. 2019 Mar - Apr; 37(2):148-158.
-
Wolf R, Parish LC, Parish JL. Commentary: The rash from nuisance to life-threatening. Clin Dermatol. 2019 Mar - Apr; 37(2):85-87.
-
Shroff RT, Yarchoan M, O'Connor A, Gallagher D, Zahurak ML, Rosner G, Ohaji C, Sartorius-Mergenthaler S, Subbiah V, Zinner R, Azad NS. The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma. Br J Cancer. 2017 May 23; 116(11):1402-1407.
-
Hyle EP, Alame D. Case records of the Massachusetts General Hospital. Case 13-2015. A 27-year-old woman with arthralgias and a rash. N Engl J Med. 2015 Apr 23; 372(17):1657-64.
-
Manian FA, Alame D. Case records of the Massachusetts General Hospital. Case 11-2015. A 28-year-old woman with headache, fever, and a rash. N Engl J Med. 2015 Apr 09; 372(15):1454-62.
-
Falchook GS, Naing A, Hong DS, Zinner R, Fu S, Piha-Paul SA, Tsimberidou AM, Morgan-Linnell SK, Jiang Y, Bastida C, Wheler JJ, Kurzrock R. Dual EGFR inhibition in combination with anti-VEGF treatment: a phase I clinical trial in non-small cell lung cancer. Oncotarget. 2013 Jan; 4(1):118-27.